Pancreatic Cancer Research

ResearcherShizuoka UniversityActive in the last 2 years

Aki Otake

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5008520734. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT s… Co-author DOI 10.1002/cncr.35343↗
  2. Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine. Co-author DOI 10.1007/s00228-017-2260-0↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daiki Tsuji · 2 shared papers, 2017–2024 · strength 0.22
  2. Kunihiko Itoh · 2 shared papers, 2017–2024 · strength 0.22
  3. Takashi Yokokawa · 1 shared paper, 2024 · strength 0.16
  4. Hiroshi Ishii · 1 shared paper, 2024 · strength 0.16
  5. Ken-ichi Suzuki · 1 shared paper, 2024 · strength 0.16
  6. Masahiro Hatori · 1 shared paper, 2024 · strength 0.16
  7. Naoki Sasahira · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.